Director Carl John Soderberg receives 919-share equity grant at Camden National (NASDAQ: CAC)

Rhea-AI Filing Summary

Soderberg Carl John reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp director Carl John Soderberg received a grant of 919 shares of Common Stock as equity compensation. The award was made under the Independent Directors' Equity Compensation Program, which is part of the 2022 Equity and Incentive Plan and its amendment.

The shares were granted at no cash cost and vested immediately on the grant date. Following this award, Soderberg directly holds a total of 104,041.218 shares of Camden National Corp common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Soderberg Carl John

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common	919	$0.00	--

Holdings After Transaction: Common — 104,041.218 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Equity grant: 919 shares Grant price: $0.0000 per share Post-transaction holdings: 104,041.218 shares +2 more

5 metrics

Equity grant 919 shares Common Stock granted as compensation on 2026-06-01

Grant price $0.0000 per share Reported transaction price for the 919-share award

Post-transaction holdings 104,041.218 shares Total direct ownership after the grant

Transaction code A (Grant, award, or other acquisition) Non-derivative common stock transaction classification

Vesting status Immediate vesting Shares vested on the date of grant

Key Terms

Independent Directors' Equity Compensation Program, 2022 Equity and Incentive Plan, Grant, award, or other acquisition, Form 4

4 terms

Independent Directors' Equity Compensation Program financial

"Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan..."

2022 Equity and Incentive Plan financial

"..., a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Soderberg Carl John

(Last) (First) (Middle)

2 ELM STREET

PO BOX 310

(Street)

CAMDEN MAINE 04843

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common	06/01/2026		A		919	A	$0(1)	104,041.218	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A. These shares vested immediately on the date of the grant.

Remarks:

	Christopher G. Hutchinson, POA	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Camden National Corp (CAC) director Carl John Soderberg report on this Form 4?

Carl John Soderberg reported receiving a grant of 919 shares of Camden National Corp common stock. The shares were issued as equity compensation under the Independent Directors' Equity Compensation Program and vested immediately on the grant date.

How many Camden National Corp (CAC) shares did Carl John Soderberg acquire in this transaction?

Carl John Soderberg acquired 919 shares of Camden National Corp common stock in this transaction. The grant was classified as a compensation-related award, with no cash price per share and immediate vesting on the date of grant.

What is Carl John Soderberg’s total Camden National Corp (CAC) holdings after this Form 4 grant?

After the 919-share grant, Carl John Soderberg directly holds 104,041.218 shares of Camden National Corp common stock. This figure reflects his post-transaction ownership as reported, showing his ongoing equity stake as a company director.

Was the Camden National Corp (CAC) Form 4 transaction an open-market purchase or sale?

The Form 4 transaction was not an open-market purchase or sale. It was a grant or award acquisition of 919 shares under an equity compensation program, with a reported price of 0.0000 per share and immediate vesting.

Under what plan were the Camden National Corp (CAC) shares granted to Carl John Soderberg?

The 919 shares granted to Carl John Soderberg were issued under the Independent Directors' Equity Compensation Program. This program is a component of Camden National Corp’s 2022 Equity and Incentive Plan and its amendment, as described in the Form 4 footnote.

Did the equity award to Carl John Soderberg in Camden National Corp (CAC) vest immediately?

Yes, the equity award vested immediately. The footnote states that the 919 shares granted under the Independent Directors' Equity Compensation Program vested in full on the date of grant, meaning there is no remaining vesting schedule associated with this award.